Proposed Data Collections Submitted for Public Comment and Recommendations, 7441-7442 [E9-3352]

Download as PDF Federal Register / Vol. 74, No. 30 / Tuesday, February 17, 2009 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60 Day–09–0539] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 or send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance Officer, 1600 Clifton Road, MS D–74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project sroberts on PROD1PC70 with NOTICES Estimating the Capacity for National and State-Level Colorectal Cancer Screening through a Survey of Endoscopic Capacity (SECAP II)— Reinstatement with Changes—Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). VerDate Nov<24>2008 19:45 Feb 13, 2009 Jkt 217001 Background and Brief Description Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States (U.S.). Removal of precancerous polyps before they transform into cancer can prevent colorectal cancer from developing. Additionally, early asymptomatic cancers found through screening respond better to treatment than more advanced cancers that are detected once they become symptomatic. As a result, CRC is ideally suited for prevention and early detection through regular screening. Flexible sigmoidoscopy and colonoscopy, two lower gastrointestinal (GI) endoscopic procedures currently recommended as colorectal cancer screening tests, provide direct visualization of the colon, and allow qualified medical professionals to identify and remove polyps as well as to detect early cancers. Both of these tests require specialized training. Flexible sigmoidoscopy provides a view of only the lower half of the colon, but is still used widely. Colonoscopy, which provides a view of the entire colon, is both a primary screening test and the recommended follow-up procedure for any other positive colorectal cancer screening test. Information regarding the capacity of the U.S. health care system to provide lower GI endoscopic procedures is critical to planning widespread CRC screening programs. In 2002, CDC conducted the National Survey of Endoscopic Capacity (SECAP) (OMB No. 0920–0539, exp. 3/31/2003) to obtain an estimate of the number of colorectal cancer screening and followup tests currently being performed, as well as the maximum number of screening and follow-up tests that could be performed in the event of widespread screening. In 2003–2005, CDC conducted similar surveys in 15 selected states to provide estimates at state and sub-state levels (State Survey of Endoscopic Capacity, OMB No. 0920–0590, exp. 6/30/2006). These capacity estimates provided critical information that helped in the planning of national and state colorectal cancer screening efforts. However, in light of recent trends in colorectal cancer screening (e.g. , increases in the percentage of public and private insurers that reimburse for screening PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 7441 colonoscopy, increased use of colonoscopy and decreased use of flexible sigmoidoscopy, availability of other colorectal cancer screening procedures), there is a need to update estimates of endoscopic capacity to guide continued screening initiatives. CDC plans to request OMB approval for three years to conduct a national survey of endoscopic capacity again in 2009–2010, and additional state-level surveys over a three-year period. The proposed national survey will employ the same methodology used in the previous national survey, and the same—but updated—sampling frame. The proposed state-level information collection will include a census survey of selected states, based on methodology employed with the previously fielded state-based survey. The target population for the national survey will be all facilities in the U.S. that use lower gastrointestinal flexible endoscopic equipment for the detection of colorectal cancer in adults. Information will be collected from a random sample of 1,800 facilities, stratified by U.S. Census region and urban/rural location. Similarly, information will be collected from a census of qualifying facilities in up to 18 selected states. An average of 200 facilities will participate in each state capacity survey. The total estimated number of respondents for the state capacity surveys is 3,600 facilities. The same survey instrument will be used for both information collections. Minor, non-substantive changes to the selfadministered, paper-and-pencil survey instrument will be made to improve usability. The specific aims of the information collection are to provide: (1) Current estimates of the number of colorectal cancer screening and follow-up procedures being performed; (2) current estimates of the maximum number of procedures that could be performed in the event of widespread screening; and (3) information regarding the types of facilities and providers that perform the procedures. Facilities will be recruited and screened through a telephone interview. Participation is voluntary and there are no costs to respondents other than their time. E:\FR\FM\17FEN1.SGM 17FEN1 7442 Federal Register / Vol. 74, No. 30 / Tuesday, February 17, 2009 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Average burden per response (in hours) Number of respondents Number of responses per respondent State Survey Recruitment Interview 1,400 1 5/60 117 State SECAP Survey ....................... National Survey Recruitment Interview. National SECAP Survey .................. 1,200 700 1 1 25/60 5/60 500 58 600 1 25/60 250 .......................................................... ........................ ........................ ........................ 925 Type of respondent Form name Medical Facilities that Perform CRC Screening. Total ........................................... Dated: February 6, 2009 Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–3352 Filed 2–13–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry(NCEH/ATSDR) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC and NCEH/ ATSDR announce the following meeting of the aforementioned committee. Times and Dates: 11 a.m.–11:30 a.m., March 4, 2009. Place: This meeting will be held by conference call. The call in number is (877) 315–6535 and enter passcode: 383520. Status: The teleconference meeting is open to the public. Purpose: The Secretary, Department of Health and Human Services (HHS) and by delegation, the Director, CDC, and Administrator, NCEH/ATSDR, are authorized under Section 301(42 U.S.C. 241) and Section 311(42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1) Conduct, encourage, cooperate with, and assist other appropriate public authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention of physical and mental diseases and other impairments; (2) assist states and their political subdivisions in the prevention of infectious diseases and other preventable conditions and in the promotion of health and well being; and (3) train state and local personnel in health work. The BSC, NCEH/ ATSDR provides advice and guidance to the Secretary, HHS; the Director, CDC; the Administrator, ATSDR; and the Director, NCEH/ATSDR, regarding program goals, objectives, strategies, and priorities in fulfillment of the agency’s mission to protect and promote people’s health. The board provides advice and guidance that will assist NCEH/ATSDR in ensuring scientific quality, timeliness, utility, and dissemination of results. The board also provides guidance to help NCEH/ATSDR work more efficiently and effectively with its various constituents and to fulfill its mission in protecting America’s health. Matters To Be Discussed: The teleconference meeting will be convened to approve/vote on the Report on the Peer Review and Clearance Policies and Practices in the National Center for Environmental Health and the Agency for Toxic Substances and Disease Registry. Agenda items are tentative and subject to change as priorities dictate. For More Information Contact: Sandra Malcom, Committee Management Specialist, NCEH/ATSDR, 4770 Buford Highway, Mail Stop F–61, Chamblee, Georgia 30345; telephone 770/488–0575, fax 770/488–3377; E-mail: smalcom@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and NCEH/ATSDR. Dated: February 11, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–3351 Filed 2–13–09; 8:45 am] BILLING CODE 4163–18–P Total burden (in hours) DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request Title: Communities Empowering Youth (CEY) Program Evaluation. OMB No.: 0970–0335. Description: This proposed information collection activity is to obtain information from Communities Empowering Youth (CEY) grantee agencies and the faith-based and community organizations working in partnership with them. The CEY evaluation is an important opportunity to examine the outcomes achieved through this component of the Compassion Capital Fund in meeting its objective of improving the capacity of faith-based and community organizations and the partnerships they form to increase positive youth development and address youth violence, gang involvement, and child abuse/neglect. The evaluation will be designed to assess changes and improvements in the structure and functioning of the partnership and the organizational capacity of each participating organization. The purpose of this request is to revise the approved baseline instrument for follow-up data collection. Respondents: CEY grantees and the faith-based and community organizations that are a part of the partnership approved under the CEY grant are respondents. sroberts on PROD1PC70 with NOTICES ANNUAL BURDEN ESTIMATES Annual number of respondents Instrument Follow-up Survey ............................................................................................................. VerDate Nov<24>2008 19:45 Feb 13, 2009 Jkt 217001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 Number of responses per respondent 354 1 E:\FR\FM\17FEN1.SGM 17FEN1 Average burden hours per response .466 Total annual burden hours 165

Agencies

[Federal Register Volume 74, Number 30 (Tuesday, February 17, 2009)]
[Notices]
[Pages 7441-7442]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3352]



[[Page 7441]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60 Day-09-0539]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 or 
send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS D-74, Atlanta, GA 30333 or send an e-
mail to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Estimating the Capacity for National and State-Level Colorectal 
Cancer Screening through a Survey of Endoscopic Capacity (SECAP II)--
Reinstatement with Changes--Division of Cancer Prevention and Control, 
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Colorectal cancer (CRC) is the second leading cause of cancer-
related deaths in the United States (U.S.). Removal of pre-cancerous 
polyps before they transform into cancer can prevent colorectal cancer 
from developing. Additionally, early asymptomatic cancers found through 
screening respond better to treatment than more advanced cancers that 
are detected once they become symptomatic. As a result, CRC is ideally 
suited for prevention and early detection through regular screening. 
Flexible sigmoidoscopy and colonoscopy, two lower gastrointestinal (GI) 
endoscopic procedures currently recommended as colorectal cancer 
screening tests, provide direct visualization of the colon, and allow 
qualified medical professionals to identify and remove polyps as well 
as to detect early cancers. Both of these tests require specialized 
training. Flexible sigmoidoscopy provides a view of only the lower half 
of the colon, but is still used widely. Colonoscopy, which provides a 
view of the entire colon, is both a primary screening test and the 
recommended follow-up procedure for any other positive colorectal 
cancer screening test.
    Information regarding the capacity of the U.S. health care system 
to provide lower GI endoscopic procedures is critical to planning 
widespread CRC screening programs. In 2002, CDC conducted the National 
Survey of Endoscopic Capacity (SECAP) (OMB No. 0920-0539, exp. 3/31/
2003) to obtain an estimate of the number of colorectal cancer 
screening and follow-up tests currently being performed, as well as the 
maximum number of screening and follow-up tests that could be performed 
in the event of widespread screening. In 2003-2005, CDC conducted 
similar surveys in 15 selected states to provide estimates at state and 
sub-state levels (State Survey of Endoscopic Capacity, OMB No. 0920-
0590, exp. 6/30/2006). These capacity estimates provided critical 
information that helped in the planning of national and state 
colorectal cancer screening efforts. However, in light of recent trends 
in colorectal cancer screening (e.g. , increases in the percentage of 
public and private insurers that reimburse for screening colonoscopy, 
increased use of colonoscopy and decreased use of flexible 
sigmoidoscopy, availability of other colorectal cancer screening 
procedures), there is a need to update estimates of endoscopic capacity 
to guide continued screening initiatives.
    CDC plans to request OMB approval for three years to conduct a 
national survey of endoscopic capacity again in 2009-2010, and 
additional state-level surveys over a three-year period. The proposed 
national survey will employ the same methodology used in the previous 
national survey, and the same--but updated--sampling frame. The 
proposed state-level information collection will include a census 
survey of selected states, based on methodology employed with the 
previously fielded state-based survey.
    The target population for the national survey will be all 
facilities in the U.S. that use lower gastrointestinal flexible 
endoscopic equipment for the detection of colorectal cancer in adults. 
Information will be collected from a random sample of 1,800 facilities, 
stratified by U.S. Census region and urban/rural location. Similarly, 
information will be collected from a census of qualifying facilities in 
up to 18 selected states. An average of 200 facilities will participate 
in each state capacity survey. The total estimated number of 
respondents for the state capacity surveys is 3,600 facilities. The 
same survey instrument will be used for both information collections. 
Minor, non-substantive changes to the self-administered, paper-and-
pencil survey instrument will be made to improve usability.
    The specific aims of the information collection are to provide: (1) 
Current estimates of the number of colorectal cancer screening and 
follow-up procedures being performed; (2) current estimates of the 
maximum number of procedures that could be performed in the event of 
widespread screening; and (3) information regarding the types of 
facilities and providers that perform the procedures.
    Facilities will be recruited and screened through a telephone 
interview. Participation is voluntary and there are no costs to 
respondents other than their time.

[[Page 7442]]



                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                             Number of    Average burden
               Type of respondent                               Form name                    Number of     responses per   per response    Total burden
                                                                                            respondents     respondent      (in hours)      (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Medical Facilities that Perform CRC Screening..  State Survey Recruitment Interview.....           1,400               1            5/60             117
                                                 State SECAP Survey.....................           1,200               1           25/60             500
                                                 National Survey Recruitment Interview..             700               1            5/60              58
                                                 National SECAP Survey..................             600               1           25/60             250
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................  ..............  ..............  ..............             925
--------------------------------------------------------------------------------------------------------------------------------------------------------


    Dated: February 6, 2009
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
 [FR Doc. E9-3352 Filed 2-13-09; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.